Careers Investor Relations Education & Training Portal Logins CONTACT PRODUCTS & SERVICES THERAPEUTIC AREAS CUSTOMER SUPPORT ABOUT US Who We Are Our Inspiration Locations Corporate Social Responsibility Humane Care Initiative Eureka Science Community Investor Relations News & Events Careers News & Events News & Events Featured Stories Media Coverage Press Releases Conferences Press Resources Media Coverage James Foster Interview on Mad Money with Jim Cramer 01/14/2015 Live from the JP Morgan Healthcare Conference, James Foster, chairman and CEO at Charles River Laboratories spoke with Mad Money on CNBC. James Foster and Jim Cramer discuss the company’s strategic focus on helping accelerate drug discovery and development. On the Hunt Against Huntington’s Disease 12/15/2014 CHDI Foundation, Inc. has extended its ongoing collaboration with Charles River Laboratories for discovering novel drugs for Huntington's disease for an additional five years. Development of a Viral Induction Study for Cell Bank Characterization 11/15/2014 An approach to consider for detecting latent or endogenous viruses in cell substrates is the use of assays that employ specific chemical compounds to induce virus expression or replication. Following induction, latent and endogenous viruses can then be detected through subsequent assays, such as TEM and QF-PCR testing. Ready, Aim, CRISPR (or RNAi) 11/15/2014 When targeting genes, drug developers may opt for knockdown via CRISPR or silencing via RNAi. These weapons, however, may fit different battle plans. Overcoming Cell Line Complacency 11/15/2014 Don’t fall into the cell line misidentification trap. Authenticate! What you don’t know–or what you refuse to acknowledge–will hurt you. Charles River's Early Drug Discovery Business and CHDI Foundation Extend Huntington's Disease Collaboration 11/07/2014 Today, Charles River Laboratories announced that CHDI Foundation, Inc. has extended its ongoing collaboration for an additional five years. The collaboration, which began in 2005, is focused on discovering novel drugs for Huntington's disease. CHDI has expanded the collaboration with Charles River due to its neuroscience expertise and comprehensive integrated drug discovery capability. Will Pharma Talent Help Transform CROs Into CSOs? 11/05/2014 It's no secret that Big Pharma is shedding scientific talent, which is migrating to smaller biotech companies and CROs. As Big Pharma continues to shrink, they will rely even more on those two segments. With more scientific talent in those areas, it can be a win/win situation. The Essential Elements of a Good Sponsor/CRO Relationship 11/05/2014 The pharma/CRO relationship can be a complicated one. Each side knows what it wants to gain from the relationship, but those goals or the route to achieve them do not always align. Having a fundamental understanding of what the other side is hoping to accomplish is critical to the relationship developing and maturing in a productive and harmonious manner. Timely Deals Boost Charles River's Balance Sheet 11/03/2014 A string of acquisitions has revenue rolling at Charles River Laboratories, and the CRO has inked another M&A deal it hopes will pay off with a larger market share. James Foster Interview on Mad Money with Jim Cramer 10/30/2014 In this interview, James Foster, chairman and CEO at Charles River Laboratories spoke about the Company's Q3 earnings, the acquisition of ChanTest and why the work we do is so important. DISPLAYING RESULTS 1-10 (OF 52) |< < 1 - 2 - 3 - 4 - 5 - 6 > >| Contact Us Our experts are available to answer any questions or discuss a quote. From: North America Europe Asia Other Call us at: 1.877.CRIVER.1 (1.877.274.8371) EMAIL US Careers Press Resources Investor Relations Legal Compliance Policies Connect with Us: RSS Twitter Facebook LinkedIn YouTube © 2021 Charles River Laboratories International, Inc. Legal Terms & Conditions Privacy Policy Safe Harbor Privacy Policy Products & Services Research Models & Services Discovery Services Preclinical Services Biologics Testing Solutions Endotoxin Detection & Microbial Identification Avian Vaccine Services Chemicals, Agro & Vet Therapeutic Areas Cardiovascular Central Nervous System Inflammation Metabolic Disease Musculoskeletal Disease Oncology Ophthalmology Respiratory Disease Contact Us Locations Initiate a Project News & Events What's New at Charles River Education & Training Eureka Science Community